{"id":6780,"date":"2025-09-11T23:02:48","date_gmt":"2025-09-11T23:02:48","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/09\/11\/lasker-award-cycstic-fibrosis-treatments\/"},"modified":"2025-09-11T23:02:48","modified_gmt":"2025-09-11T23:02:48","slug":"lasker-award-cycstic-fibrosis-treatments","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/09\/11\/lasker-award-cycstic-fibrosis-treatments\/","title":{"rendered":"STAT+: Scientists who revolutionized cystic fibrosis treatment win prestigious Lasker Award"},"content":{"rendered":"

STAT+: Scientists who revolutionized cystic fibrosis treatment win prestigious Lasker Award
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

Three scientists who revolutionized the treatment of cystic fibrosis and prolonged the lifespan of patients with the deadly disease have won the Lasker Award, one of the most prestigious awards in medicine.<\/p>\n

Vertex Pharmaceuticals researcher Paul Negulescu, former Vertex researcher Jes\u00fas (Tito) Gonz\u00e1lez, and University of Iowa professor Michael Welsh, will share the $250,000 prize. The Lasker DeBakey Clinical Medical Research Award, as it\u2019s formally known, is given for a \u201cmajor advance that improves the lives of thousands of people,\u201d according to the Lasker Foundation.<\/p>\n

\u201cIt\u2019s not only gratifying and rewarding,\u201d said Negulescu, a senior vice president at Vertex. \u201cOur hope is that our work can serve as lessons for other research.\u201d<\/p>\n

Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Yogev Toby \u2014\u00a0Boston Globe
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

STAT+: Scientists who revolutionized cystic fibrosis treatment win prestigious Lasker Award Three scientists who revolutionized the treatment of cystic fibrosis and prolonged the lifespan of patients with the deadly disease have won the Lasker Award, one of the most prestigious awards in medicine. Vertex Pharmaceuticals researcher Paul Negulescu, former Vertex researcher Jes\u00fas (Tito) Gonz\u00e1lez, and […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,1428,2218,2155,858,2152,2566],"tags":[2150],"class_list":["post-6780","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-health","category-in-the-lab","category-pharmaceuticals","category-research","category-stat","category-vertex","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6780"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=6780"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6780\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=6780"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=6780"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=6780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}